Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytori Therapeutics Inc (NASDAQ:CYTX)

1.55
Delayed Data
As of Jan 20
 -0.05 / -3.13%
Today’s Change
1.36
Today|||52-Week Range
5.44
+2.65%
Year-to-Date
No recent news for Cytori Therapeutics Inc.

Today’s Trading

Previous close1.60
Today’s open1.58
Day’s range1.51 - 1.60
Volume108,345
Average volume (3 months)171,424
Market cap$32.0M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+70.83%
Earnings growth (this year)+38.10%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales5.38
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
DXRDaxor Corp0.000.00%
----
ATECAlphatec Holdings In...+0.01+0.29%
MGCDMGC Diagnostics Corp+0.01+0.10%
Data as of 3:59pm ET, 01/20/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$4.8M
Annual profit (last year)-$19.4M
Net profit margin-401.10%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Marc H. Hedrick
CFO, Vice President &
Head-Investor Relations
Tiago Girão
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs